Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-22
DOI
10.3389/fmicb.2021.749685
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Experiencia con el uso de dalbavancina en la infección profunda de pie diabético
- (2021) Gema Navarro-Jiménez et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review
- (2021) Morgan Matt et al. Journal of Global Antimicrobial Resistance
- Prosthetic Shoulder Joint Infection by Cutibacterium acnes: Does Rifampin Improve Prognosis? A Retrospective, Multicenter, Observational Study
- (2021) Helem Vilchez et al. Antibiotics-Basel
- Eradicating biofilm infections: an update on current and prospective approaches
- (2021) Ronni A G da Silva et al. CURRENT OPINION IN MICROBIOLOGY
- Biofilm-active antibiotic treatment improved the outcome of knee periprosthetic joint infection: Results from a 6-year prospective cohort
- (2020) Max Gellert et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibiofilm and intraosteoblastic activities of rifamycins against Staphylococcus aureus: promising in vitro profile of rifabutin
- (2020) Lélia Abad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs)
- (2020) Alex Soriano et al. Expert Review of Anti-Infective Therapy
- Outcome of spinal implant-associated infections treated with or without biofilm-active antibiotics: results from a 10-year cohort study
- (2020) Karolin Köder et al. INFECTION
- Efficacy of dalbavancin against MRSA biofilms in a rat model of orthopaedic implant-associated infection
- (2020) Vanessa Silva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dalbavancin for the management of osteomyelitis: a major step forward?
- (2020) Thamer A Almangour et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Biofilm Matrixome: Extracellular Components in Structured Microbial Communities
- (2020) L. Karygianni et al. TRENDS IN MICROBIOLOGY
- Effect of Dalbavancin on Staphylococcal Biofilms When Administered Alone or in Combination With Biofilm-Detaching Compounds
- (2020) Miglë Žiemytė et al. Frontiers in Microbiology
- Biofilm dispersion
- (2020) Kendra P. Rumbaugh et al. NATURE REVIEWS MICROBIOLOGY
- Comparison of dalbavancin to standard of care for outpatient treatment of invasive Gram-positive infections
- (2020) Michael P. Veve et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effectiveness, safety and cost analysis of dalbavancin in clinical practice
- (2020) Maria Arrieta-Loitegui et al. European Journal of Hospital Pharmacy-Science and Practice
- Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population
- (2019) Chloe Bryson-Cahn et al. Open Forum Infectious Diseases
- Clinical experience with dalbavancin for the treatment of deep sternal wound infection
- (2019) Michele Bartoletti et al. Journal of Global Antimicrobial Resistance
- Safety and efficacy of prolonged use of dalbavancin in bone and joint infections
- (2019) L. Morata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States
- (2019) Keith S Kaye et al. CLINICAL INFECTIOUS DISEASES
- Multicenter clinical experience of real life Dalbavancin use in gram-positive infections
- (2019) S. Wunsch et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
- (2019) Taylor Morrisette et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antibiotics versus biofilm: an emerging battleground in microbial communities
- (2019) Divakar Sharma et al. Antimicrobial Resistance and Infection Control
- Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017
- (2019) Lin Huang et al. Antimicrobial Resistance and Infection Control
- The MSCRAMM Family of Cell-Wall-Anchored Surface Proteins of Gram-Positive Cocci
- (2019) Timothy J. Foster TRENDS IN MICROBIOLOGY
- Chronic Implant-Related Bone Infections—Can Immune Modulation be a Therapeutic Strategy?
- (2019) Elisabeth Seebach et al. Frontiers in Immunology
- In vitro Activity of Rifampin, Rifabutin, Rifapentine and Rifaximin Against Planktonic and Biofilm States of Staphylococci Isolated from Periprosthetic Joint Infection
- (2019) Mariana Albano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- French national cohort of first use of dalbavancin: a high proportion of off-label use
- (2019) Aurélien Dinh et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Dalbavancin use in an academic medical centre and associated cost savings
- (2019) Amber C. Streifel et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Serum bactericidal activity levels monitor to guide intravenous dalbavancin chronic suppressive therapy of inoperable staphylococcal prosthetic valve endocarditis: a case report
- (2019) Martina Spaziante et al. Open Forum Infectious Diseases
- Microbial biofilm correlates with an increased antibiotic tolerance and poor therapeutic outcome in infective endocarditis
- (2019) Enea Gino Di Domenico et al. BMC MICROBIOLOGY
- In vitro time-kill kinetics of dalbavancin against Staphylococcus spp. biofilms over prolonged exposure times
- (2019) Vincenzo Di Pilato et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
- (2019) Carmen Hidalgo-Tenorio et al. Annals of Clinical Microbiology and Antimicrobials
- Debridement, antibiotics, and implant retention for periprosthetic knee infections: a pooling analysis of 1266 cases
- (2019) Guo-Xin Qu et al. Journal of Orthopaedic Surgery and Research
- Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
- (2018) Selma Tobudic et al. CLINICAL INFECTIOUS DISEASES
- Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen
- (2018) B.J. Werth et al. CLINICAL MICROBIOLOGY AND INFECTION
- Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci
- (2018) Katharina Neudorfer et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Dalbavancin in the treatment of different gram-positive infections: a real-life experience
- (2018) Emilio Bouza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Bacterial adhesion at the single-cell level
- (2018) Cecile Berne et al. NATURE REVIEWS MICROBIOLOGY
- Attempted salvage of infected cardiovascular implantable electronic devices: Are there clinical factors that predict success?
- (2018) James E. Peacock et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility
- (2018) Thamer A. Almangour et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Biofilm-associated infection by enterococci
- (2018) Jun-Hong Ch’ng et al. NATURE REVIEWS MICROBIOLOGY
- Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis
- (2018) Manuel Kussmann et al. Emerging Microbes & Infections
- Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety
- (2018) Urania Rappo et al. Open Forum Infectious Diseases
- Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new
- (2017) Michael Z. David et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin
- (2017) J. M. Steele et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Surface modification strategies for combating catheter-related complications: recent advances and challenges
- (2017) Koon Gee Neoh et al. Journal of Materials Chemistry B
- Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin
- (2016) Ara Jo et al. BMC MICROBIOLOGY
- In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections
- (2016) Javier Fernández et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
- (2016) D. Knafl et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms
- (2016) María Lázaro-Díez et al. PLoS One
- Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?
- (2016) Ana M. Guzman Prieto et al. Frontiers in Microbiology
- Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue
- (2015) Michael W. Dunne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection
- (2015) Michael W. Dunne et al. CLINICAL INFECTIOUS DISEASES
- ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014
- (2015) N. Høiby et al. CLINICAL MICROBIOLOGY AND INFECTION
- Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
- (2015) Steven Y. C. Tong et al. CLINICAL MICROBIOLOGY REVIEWS
- Bactericidal activity of ceftaroline against mature Staphylococcus aureus biofilms
- (2015) Giulia Landini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Methicillin resistance and the biofilm phenotype in Staphylococcus aureus
- (2015) Hannah McCarthy et al. Frontiers in Cellular and Infection Microbiology
- Extracellular DNA Impedes the Transport of Vancomycin in Staphylococcus epidermidis Biofilms Preexposed to Subinhibitory Concentrations of Vancomycin
- (2014) Natalya Doroshenko et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High Activity of Fosfomycin and Rifampin against Methicillin-Resistant Staphylococcus aureus Biofilm In Vitro and in an Experimental Foreign-Body Infection Model
- (2014) R. Mihailescu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Aminoglycoside inhibition of Staphylococcus aureus biofilm formation is nutrient dependent
- (2014) M. J. Henry-Stanley et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
- (2014) D. Lebeaux et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
- (2014) Helen W. Boucher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Staphylococcus aureus biofilms: recent developments in biofilm dispersal
- (2014) Jessica L. Lister et al. Frontiers in Cellular and Infection Microbiology
- Antibiotic lock therapy: review of technique and logistical challenges
- (2014) Brandon Bookstaver et al. Infection and Drug Resistance
- In VitroEfficacies and Resistance Profiles of Rifampin-Based Combination Regimens for Biofilm-Embedded Methicillin-Resistant Staphylococcus aureus
- (2013) Hung-Jen Tang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of Fosfomycin and Rifampin on Planktonic and Adherent Enterococcus faecalis Strains in an Experimental Foreign-Body Infection Model
- (2013) Alessandra Oliva et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Surveillance of dalbavancin potency and spectrum in the United States (2012)
- (2013) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model
- (2013) Daniela Baldoni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Biofilm infections, their resilience to therapy and innovative treatment strategies
- (2013) U. Römling et al. JOURNAL OF INTERNAL MEDICINE
- Role of Rifampin against Propionibacterium acnes BiofilmIn Vitroand in an Experimental Foreign-Body Infection Model
- (2012) Ulrika Furustrand Tafin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms
- (2012) H.-J. Tang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm
- (2012) J. Parra-Ruiz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro Activity of Daptomycin, Linezolid and Rifampicin on Staphylococcus epidermidis Biofilms
- (2011) Bruna Leite et al. CURRENT MICROBIOLOGY
- Pathogenesis and immunity in enterococcal infections
- (2010) I.G. Sava et al. CLINICAL MICROBIOLOGY AND INFECTION
- Infection Associated with Prosthetic Joints
- (2009) Jose L. Del Pozo et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started